Medicare Enrolled
Dr. Joshua Meeks, MD, PHD
Urology Physician · Chicago, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Meeks from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Meeks?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Meeks
Dr. Joshua Meeks is an urology physician in Chicago, IL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Meeks performed 20,705 Medicare services across 1,068 unique beneficiaries.
Between the years covered by Open Payments, Dr. Meeks received a total of $228,619 from 26 pharmaceutical and/or device companies across 251 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Meeks is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 4% volume in IL
$228,619 industry payments
Medicare Practice Summary
Medicare Utilization ↗20,705
Medicare services
Top 4% in IL for urology physician
1,068
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,218 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 11,449 | $2 | $10 |
| Injection, docetaxel, 1 mg | 6,572 | $1 | $34 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 1,010 | $3 | $105 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
498 | $71 | $677 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
342 | $188 | $1,163 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
181 | $74 | $219 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
144 | $33 | $511 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
76 | $74 | $175 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
56 | $94 | $323 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
52 | $103 | $250 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
38 | $231 | $2,045 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
26 | $111 | $1,042 |
| Bladder procedure using endoscope A procedure performed on the bladder using an endoscope, which is a thin, flexible tube with a camera used to view the inside of the organ. |
25 | $1,869 | $8,621 |
| Bladder biopsy using endoscope A procedure to remove a small tissue sample from the bladder using a thin, flexible tube with a camera. The sample is then examined to check for abnormalities. |
24 | $86 | $863 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
24 | $20 | $95 |
| Bladder/urethra growth removal via endoscope, 0.5-2.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 0.5 and 2.0 centimeters. |
22 | $193 | $1,311 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $133 | $534 |
| Bladder tumor removal via endoscope This procedure involves using an endoscope to destroy or remove a large growth from the bladder. |
19 | $296 | $2,988 |
| New patient office visit, complex (60-74 min) | 18 | $174 | $673 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
17 | $43 | $100 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
16 | $8 | $230 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $44 | $132 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
16 | $149 | $434 |
| Cystourethroscopy with ureteroscopy or pyeloscopy A diagnostic procedure using an endoscope to examine the bladder, urethra, and ureter or kidney. |
15 | $229 | $2,100 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
15 | $517 | $9,482 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
13 | $141 | $2,755 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
36.9% medium
62.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$228,619
Total received (2018-2024)
Avg $32,660/year across 7 years
Top 2% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
251
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$179,405 (78.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$47,535 (20.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,679 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$43,935
2023
$39,769
2022
$16,027
2021
$34,308
2020
$28,927
2019
$29,283
2018
$36,369
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Research & Development, LLC
$21,986
Olympus Corporation of the Americas
$7,995
AstraZeneca UK Limited
$3,398
Ferring Pharmaceuticals Inc.
$2,604
IMMUNITYBIO, INC.
$2,400
Merck Sharp & Dohme LLC
$2,360
PFIZER INC.
$1,614
AstraZeneca Pharmaceuticals LP
$1,342
Janssen Global Services, LLC
$127
Medical Device Business Services, Inc.
$108
Top 3 companies account for 76.0% of 2024 payments
All-time payments by company (2018-2024) ›
Olympus Corporation of the Americas
$43,071
Janssen Research & Development, LLC
$38,961
AstraZeneca Pharmaceuticals LP
$25,652
Ferring Pharmaceuticals Inc.
$23,701
AstraZeneca UK Limited
$21,061
Janssen Global Services, LLC
$18,183
UROGEN PHARMA, INC.
$11,676
Ferring Pharmaceuticals AS
$11,284
Merck Sharp & Dohme Corporation
$9,650
Foundation Medicine, Inc.
$4,387
E.R. Squibb & Sons, L.L.C.
$3,814
Merck Sharp & Dohme LLC
$3,722
Astellas Pharma Global Development
$3,599
PFIZER INC.
$2,811
IMMUNITYBIO, INC.
$2,400
UroGen Pharma, Inc.
$2,000
Olympus Corporation
$900
Janssen Scientific Affairs, LLC
$758
Photocure Inc
$308
Genentech, Inc.
$181
Seagen Inc.
$176
GENZYME CORPORATION
$138
Medical Device Business Services, Inc.
$108
Antares Pharma, Inc.
$44
Olympus America Inc.
$23
Hollister Incorporated
$14
Top 3 companies account for 47.1% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ANKTIVA · BALVERSA · CYSTO-NEPHRO VIDEOSCOPE · Cysview · DARZALEX · FIRMAGON · FOUNDATIONACT · HD CAMERA HEAD · IMFINZI · JELMYTO · NO PRODUCT DISCUSSED · NOCDURNA · OES CYSTONEPHROFIBERSCOPE · OPDIVO · Olympus · Olympus Cystoscopes · Olympus Laser Devices · PADCEV · Padcev · Single Use Grasping Forceps FG-253SX · TECENTRIQ · VaPro · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (78%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 2% for urology physician in IL.
Geographic Context
Urology physicians within 10 mi
311
Per 100K population
6.0
County median income
$81,797
Nearest hospital
NORTHWESTERN MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Meeks is a mixed practice specialist, with above-average Medicare volume (top 4% in IL), with consulting-driven industry engagement in the top 2% of IL peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Meeks experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Meeks performed 11,449 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Meeks receive payments from pharmaceutical companies?
Yes. Dr. Meeks received a total of $228,619 from 26 companies across 251 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Meeks's costs compare to other urology physicians in Chicago?
Dr. Meeks's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Meeks) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Chicago
Browse urology physicians in Chicago ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
Olympus Corporation of the Americas Payments to Doctors
See all physicians who received payments from Olympus Corporation of the Americas.
By company
Janssen Research & Development, LLC Payments to Doctors
See all physicians who received payments from Janssen Research & Development, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology